Trevotamig Antibody
Trevotamig is a bispecific T-cell engager antibody of the H-γ1_L-κ-scFvhl dimer format, designed to target EpCAM and CD3. It is used in research to study T-cell-mediated cytotoxicity against EpCAM-expressing cancers in both in vitro and in vivo experimental models.
Product Specifications
Target
Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
